Merck & Co., Inc. (FRA:6MK)
Germany
· Delayed Price · Currency is EUR 73.10
+3.60 (5.18%)
Last updated: Apr 28, 2025
Merck & Co. Statistics
Total Valuation
Merck & Co. has a market cap or net worth of EUR 183.99 billion. The enterprise value is 205.64 billion.
| Market Cap | 183.99B |
| Enterprise Value | 205.64B |
Important Dates
The last earnings date was Thursday, April 24, 2025.
| Earnings Date | Apr 24, 2025 |
| Ex-Dividend Date | Mar 17, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.30% |
| Shares Change (QoQ) | -0.24% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 2.51B |
Valuation Ratios
The trailing PE ratio is 11.41.
| PE Ratio | 11.41 |
| Forward PE | n/a |
| PS Ratio | 3.11 |
| PB Ratio | 4.29 |
| P/TBV Ratio | 24.03 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 12.75 |
| EV / Sales | 3.66 |
| EV / EBITDA | 7.98 |
| EV / EBIT | 9.52 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.83 |
| Debt / EBITDA | 1.31 |
| Debt / FCF | n/a |
| Interest Coverage | 19.22 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 19.17% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 799,198 |
| Profits Per Employee | 217,972 |
| Employee Count | 75,000 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -40.57% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -40.57% |
| 50-Day Moving Average | 80.47 |
| 200-Day Moving Average | 94.94 |
| Relative Strength Index (RSI) | 44.68 |
| Average Volume (20 Days) | 4,616 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.33 |
Income Statement
In the last 12 months, Merck & Co. had revenue of EUR 59.14 billion and earned 16.13 billion in profits. Earnings per share was 6.36.
| Revenue | 59.14B |
| Gross Profit | 45.58B |
| Operating Income | 22.60B |
| Pretax Income | 18.66B |
| Net Income | 16.13B |
| EBITDA | 26.66B |
| EBIT | 22.60B |
| Earnings Per Share (EPS) | 6.36 |
Balance Sheet
The company has 12.67 billion in cash and 35.41 billion in debt, giving a net cash position of -22.74 billion.
| Cash & Cash Equivalents | 12.67B |
| Total Debt | 35.41B |
| Net Cash | -22.74B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 42.90B |
| Book Value Per Share | 16.95 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 77.07%, with operating and profit margins of 38.21% and 27.27%.
| Gross Margin | 77.07% |
| Operating Margin | 38.21% |
| Pretax Margin | 31.55% |
| Profit Margin | 27.27% |
| EBITDA Margin | 45.07% |
| EBIT Margin | 38.21% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 2.93, which amounts to a dividend yield of 4.01%.
| Dividend Per Share | 2.93 |
| Dividend Yield | 4.01% |
| Dividend Growth (YoY) | 5.70% |
| Years of Dividend Growth | 7 |
| Payout Ratio | n/a |
| Buyback Yield | 0.30% |
| Shareholder Yield | 4.30% |
| Earnings Yield | 8.77% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on February 17, 1999. It was a forward split with a ratio of 2.
| Last Split Date | Feb 17, 1999 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |